CryoPort (NASDAQ:CYRX) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened

CryoPort, Inc. (NASDAQ:CYRX)’s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $11.07 and traded as high as $15.28. CryoPort shares last traded at $15.26, with a volume of 525,738 shares traded.

Analyst Ratings Changes

A number of analysts have recently commented on CYRX shares. Craig Hallum upped their price target on CryoPort from $15.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, June 3rd. BTIG Research lifted their price objective on shares of CryoPort from $15.00 to $17.00 and gave the stock a “buy” rating in a research note on Tuesday, May 5th. Jefferies Financial Group set a $13.50 price objective on shares of CryoPort in a report on Monday, June 8th. Weiss Ratings raised shares of CryoPort from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Finally, Guggenheim increased their target price on shares of CryoPort from $11.00 to $12.00 and gave the stock a “buy” rating in a report on Tuesday, May 5th. Eight analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, CryoPort currently has a consensus rating of “Moderate Buy” and an average target price of $15.11.

CryoPort Stock Up 1.3%

The firm has a fifty day simple moving average of $14.37 and a 200-day simple moving average of $11.07. The company has a market capitalization of $769.10 million, a P/E ratio of 11.30 and a beta of 1.88.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings results on Monday, May 4th. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.03). CryoPort had a negative return on equity of 7.92% and a net margin of 41.57%.The business had revenue of $47.80 million for the quarter, compared to analyst estimates of $44.86 million. On average, sell-side analysts predict that CryoPort, Inc. will post -0.85 earnings per share for the current fiscal year.

Insider Buying and Selling

In other CryoPort news, insider Edward J. Zecchini sold 33,600 shares of CryoPort stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $14.47, for a total value of $486,192.00. Following the transaction, the insider owned 109,719 shares of the company’s stock, valued at approximately $1,587,633.93. The trade was a 23.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Robert Stefanovich sold 169,427 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $16.27, for a total transaction of $2,756,577.29. Following the completion of the transaction, the chief financial officer owned 109,850 shares of the company’s stock, valued at $1,787,259.50. This trade represents a 60.67% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 227,641 shares of company stock valued at $3,622,515. 10.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On CryoPort

Several institutional investors have recently added to or reduced their stakes in CYRX. Basepoint Wealth LLC bought a new stake in CryoPort in the 4th quarter valued at $34,000. Tower Research Capital LLC TRC raised its stake in shares of CryoPort by 300.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after purchasing an additional 4,375 shares during the period. Quadrature Capital Ltd acquired a new stake in shares of CryoPort in the 4th quarter valued at about $97,000. Corient Private Wealth LLC bought a new stake in shares of CryoPort in the fourth quarter valued at about $113,000. Finally, BNP Paribas Financial Markets lifted its holdings in shares of CryoPort by 55.2% in the third quarter. BNP Paribas Financial Markets now owns 11,880 shares of the company’s stock valued at $113,000 after purchasing an additional 4,225 shares in the last quarter. 92.90% of the stock is owned by institutional investors.

About CryoPort

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.